Ticker: GSK CUSIP: 37733W204 Class: SPONSORED ADR
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 7,241,818 | $355,139 | — | — |
| Q3 2025 | 6,518,931 | $281,357 | — | — |
| Q2 2025 | 6,294,992 | $241,728 | — | — |
| Q1 2025 | 9,062,887 | $351,096 | — | — |
| Q4 2024 | 9,683,164 | $327,485 | — | — |
| Q3 2024 | 7,370,440 | $301,304 | — | — |
| Q2 2024 | 4,156,387 | $160,021 | — | — |
| Q1 2024 | 4,064,146 | $174,230 | — | — |
| Q4 2023 | 4,015,033 | $148,797 | — | — |
| Q3 2023 | 5,228,301 | $189,526 | — | — |
| Q2 2023 | 8,806,253 | $313,855 | — | — |
| Q1 2023 | 9,810,848 | $349,070 | — | — |
| Q4 2022 | 9,711,365 | $341,257 | — | — |
| Q3 2022 | 8,061,479 | $237 | — | — |